Anthony Chase, Director at Sarepta Therapeutics, holds 67.19K shares in Sarepta Therapeutics (Ticker: SRPT), holds 0.00 shares in Humanigen (Ticker: HGENQ), holds 8.80K shares in LyondellBasell (Ticker: LYB).
Anthony Chase latest transaction was an Uninformative Buy of ―.
What was Anthony Chase's most profitable transaction?
Anthony Chase’s most profitable transaction was an Informative Buy of SRPT stock on August 13, 2014. The return on the trade was 57.30%.
What is Anthony Chase's role in Sarepta Therapeutics?
Anthony Chase's role in Sarepta Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.